Allarity Therapeutics ALLR
NASDAQ ALLR
$0.89 +0.02 (+2.22%)
As of: Oct 21, 2026 · 1:24 PM EDT

Allarity Therapeutics (ALLR) Receivables - Other (2020)

Updated

Allarity Therapeutics (ALLR) posted Receivables - Other of $50,000 for Q4 2020.

Analysis

Allarity Therapeutics (ALLR) Receivables - Other (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.99 Bn 1,102.58 Bn 19.71 Bn
2 Johnson & Johnson 615.70 Bn 534.23 Bn 17.26 Bn
3 AbbVie 501.05 Bn 474.16 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.20 Bn 234.88 Bn 12.86 Bn
7 Amgen 235.55 Bn 190.95 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.29 Bn 115.93 Bn 10.94 Bn
10 Allarity Therapeutics 14.24 Mn -54.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 50,000.00
API Access

Allarity Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ALLR&period=max&api_key=YOUR_API_KEY